Cytokinetics inc stock

WebApr 6, 2024 · Cytokinetics (NASDAQ:CYTK) has a market capitalization of $3.48 billion and generates $94.59 million in revenue each year. The biopharmaceutical company earns … WebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

CYTK -- Is Its Stock Price A Worthy Investment? Learn More.

WebApr 7, 2024 · Latest Cytokinetics, Inc. Stock News As of April 06, 2024, Cytokinetics, Inc. had a $3.4 billion market capitalization, putting it in the 78th percentile of companies in … Web12 hours ago · Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cytokinetics (CYTK – Research Report) and Neurocrine (NBIX – Research Report). TipRanks has tracked 36,000 ... how to say fog in japanese https://ascendphoenix.org

Allspring Global Investments Holdings LLC Has $8.88 Million Stock ...

WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ... Cytokinetics Inc. COMPANY INFO. 34.97 ... WebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential … WebApr 14, 2024 · CYTK) stock’s latest price update. The stock of Cytokinetics Incorporated (NASDAQ: CYTK) has increased by 5.52 when compared to last closing price of 34.05.Despite this, the company has seen a loss of -0.64% in its stock price over the last five trading days. north georgia speedway - chatsworth

CYTK - Cytokinetics Inc Stock quote - CNNMoney.com

Category:Cytokinetics Incorporated (CYTK) Stock: A SWOT Analysis

Tags:Cytokinetics inc stock

Cytokinetics inc stock

CYTK Cytokinetics Inc. Stock Overview (U.S.: Nasdaq) Barron

WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential...

Cytokinetics inc stock

Did you know?

WebApr 11, 2024 · Cytokinetics, Incorporated (CYTK) Stock Historical Prices & Data - Yahoo Finance U.S. markets closed S&P 500 +22.27 Dow 30 +132.28(+0.41%) Nasdaq 11,823.96 +36.56(+0.31%) Russell 2000 1,734.92... WebNov 29, 2024 · Cytokinetics, Inc. (CYTK) stock has gained 0.67% while the S&P 500 has fallen -0.43% as of 11:42 AM on Tuesday, Nov 29. CYTK is higher by $0.27 from the previous closing price of $40.09 on volume of 312,812 shares. Over the past year the S&P 500 is lower by -15.22% while CYTK is higher by 4.10%.

WebApr 9, 2024 · In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the stock in a transaction on Monday, March 6th. The stock was sold at an average price of … WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 …

WebFind real-time CYTK - Cytokinetics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes. 35.41. … WebComplete Cytokinetics Inc. stock information by Barron's. View real-time CYTK stock price and news, along with industry-best analysis.

WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th …

WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have ... north georgia staffing rockmart gaWebStock Symbol CYTK Share Price $35.19 (As of Friday Closing) General Information Description Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by … how to say fog in frenchWebWith a price/sales ratio of 34.58, CYTOKINETICS INC has a higher such ratio than 95.52% of stocks in our set. Equity multiplier, or assets relative to shareholders' equity, comes in at 35.83 for CYTOKINETICS INC; that's greater than it is for 99.05% of US stocks. north georgia state fair marietta gaWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … how to say foliageWebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … how to say folk music in spanishWebApr 6, 2024 · Cytokinetics initiated with buy rating, $60 price target at Truist Dec. 20, 2024 at 7:41 a.m. ET by Steve Gelsi Cytokinetics started at buy with $80 stock price target at … north georgia still company\u0027sWebApr 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. north georgia still company\\u0027s